Consensus of combined modality therapy for head and neck tumors
Lu, T-Xiang.; Tang, P-Zhang.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45(7): 535-541
2010
ISSN/ISBN: 1673-0860 PMID: 21055047 Document Number: 638451
Document emailed within 1 workday
Related Documents
Zamboglou, N.; Pape, H.; Schnabel, T.; Wurm, R.; Bannach, B.; Fürst, G.; Schmitt, G. 1989: Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(9): 647-651Holsti, L.R.; Kajanti, M. 2005: More frequent radiation therapy in the treatment of head and neck tumors Duodecim; Laaketieteellinen Aikakauskirja 121(10): 1025-1026
Kawakami, T.; Watanabe, S.; Ogawara, T.; Akagi, S.; Tamura, S.; Koide, I.; Ogawa, A.; Takiguchi, S.; Masuda, Y. 1993: Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(5): 669-672
Liu, S.; Lin, Y.; Tang, S.; Yang, H.; Liang, C. 2001: IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma Hua Xi Kou Qiang Yi Xue Za Zhi 19(3): 191-193
Ganzer, U. 1985: Synchronization therapy as a palliative measure in incurable head and neck tumors Laryngologie Rhinologie Otologie 64(1): 21-24
Vazhenin, A.V.; Lukina, E.I.; Kuznetsova, A.I.; Munasipov, Z.Z.; Mokichev, G.V. 2010: Prophylaxis of early radiation injuries to intact tissues following exposure to combined photon-neutron radiotherapy for malignant head and neck tumors Voprosy Onkologii 56(4): 404-407
Federspil, P.; Elies, W.; Luckhaupt, H.; Marklein, G.; Mollenhauer, H.W.; Otten, J.E.; Otto, K.; Pelz, K.; Scholz, H.; Schrappe, M.; Seifert; Staib, A.H.; Straube, E.; Sybrecht, G.W.; Unertl, K. 2000: Antibiotic therapy for infections in the head and neck. German Society of Otorhinolaryngology, Head and Neck Surgery Hno 48(2): 91-103
Tu, G.-y.; Xu, Z.-g.; Liu, S.-y. 2009: From head and neck surgery to head and neck oncology: the disciplinary guarantee for comprehensive cancer therapy Zhonghua Zhong Liu Za Zhi 31(11): 877-879
Fountzilas, G.; Daniilidis, J.; Kalogera-Fountzila, A.; Apostolidis, T.; Vritsios, A.; Tourkantonis, A. 1988: Combined therapy of locally advanced squamous epithelial cancers in the area of the head and neck Laryngologie Rhinologie Otologie 67(4): 165-170
Gutjahr, P.; Jung, H. 1975: Contribution to the diagnosis, therapy and prognosis of head and neck tumors in childhood and adolescence: experience with 94 own cases Laryngologie Rhinologie Otologie 54(7): 591-597
Grégoire, V. 2004: Implementation of intensity-modulated radiation therapy in head and neck tumors: what are the important data for biological optimization? Rays 29(3): 271-274
Bertoni, F.; Morrica, B. 1983: Technics for irradiation of the neck in the treatment of lymph node metastases from solid tumors of the head and neck region La Radiologia Medica 69(10): 792-799
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Iannaccone, P.R. 1975: Multiple primary tumors. Four distinct head and neck tumors Archives of Pathology 99(5): 270-272
Ono, S. 2006: Combined modality therapy for cerebral vasospasm: fibrinolytic therapy using urokinase and intravascular surgery Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 633-638
Blanke, C.D.; Teng, M.; Choy, H. 1999: The role of UFT in combined-modality therapy Oncology 13(10 Suppl 5: 47-54
Glatein, E.; Donaldson, S.S.; Rosenberg, S.A.; Kaplan, H.S. 1977: Combined modality therapy in malignant lymphomas Cancer Treatment Reports 61(6): 1199-1207
Bajorin, D.F.; Herr, H.; Motzer, R.J.; Bosl, G.J. 1992: Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors Seminars in Oncology 19(2): 148-158
Minsky, B.D. 1999: Adjuvant postoperative combined-modality therapy for rectal cancer Oncology 13(7 Suppl 3: 132-135
Cho, L.C.; Choy, H. 2004: Topoisomerase i inhibitors in the combined-modality therapy of lung cancer Oncology 18(7 Suppl 4: 29-39